Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
3.32
0.27 (8.85%)
At close: Jun 06, 2025, 3:59 PM
3.31
-0.30%
After-hours: Jun 06, 2025, 04:04 PM EDT

Orchestra BioMed Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023
Product Revenue 633K 654K
Product Revenue Growth -3.21% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Selling, General, and Administrative Revenue 6.26M 5.9M 5.67M 6.47M 5.82M 4.15M 6.34M 5.32M 4.41M 876.72K 813.41K 2.95M 2.48M 92.05K 94.44K 96.32K 111.95K
Selling, General, and Administrative Revenue Growth +6.13% +4.15% -12.39% +11.06% +40.35% -34.60% +19.29% +20.56% +403.12% +7.78% -72.39% +18.89% +2592.16% -2.54% -1.94% -13.96% n/a
Research and Development Revenue 13.48M 10.97M 11.6M 11.13M 9.11M 8.51M 8.56M 8.5M 8.25M 7.54M 5.9M 5.03M 3.47M 3.53M 3.66M 2.64M 3.06M
Research and Development Revenue Growth +22.89% -5.38% +4.22% +22.10% +7.06% -0.55% +0.69% +2.97% +9.43% +27.87% +17.30% +44.76% -1.61% -3.50% +38.76% -13.91% n/a